Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors

BACKGROUND: Programmed cell death receptor ligand 1 (PD-L1) inhibitors are immune checkpoint inhibitors (ICIs) with a side effect profile that may differ from other classes of ICIs such as those directed against cytotoxic T-lymphocyte−associated protein 4 (CTLA-4) and programmed cell death 1 recepto...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Kidney Int Rep
Hlavní autoři: Seethapathy, Harish, Zhao, Sophia, Strohbehn, Ian A., Lee, Meghan, Chute, Donald F., Bates, Halla, Molina, Gabriel E., Zubiri, Leyre, Gupta, Shruti, Motwani, Shveta, Leaf, David E., Sullivan, Ryan J., Rahma, Osama, Blumenthal, Kimberly G., Villani, Alexandra-Chloe, Reynolds, Kerry L., Sise, Meghan E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569697/
https://ncbi.nlm.nih.gov/pubmed/33102962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.07.011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky